SCHEMBL7944686

SCHEMBL7944686

OC1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.51
OPRM1 P35372 2/20 0.50
OPRD1 P41143 2/20 0.50
OPRK1 P41145 2/20 0.50
OPRL1 P41146 2/20 0.50
IGF1R P08069 1/20 0.47
CACNA2D1 P54289 1/20 0.46
CACNA1B Q00975 1/20 0.46
CACNB1 Q02641 1/20 0.46
CACNA1C Q13936 1/20 0.46
MGLL Q99685 2/20 0.45
SMAD3 P84022 1/20 0.44
P4HB P07237 3/20 0.43
FAAH O00519 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28880055 0.82 HSD11B1 (0.51) OPRM1
SCHEMBL16225988 0.81 ACHE (0.51) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL6983812 0.81 ACHE (0.51) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL7275198 0.81 ACHE (0.46) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL5745201 0.81 L3MBTL3 (0.61) OPRM1OPRD1OPRK1OPRL1
Hydrochloric Acid SCHEMBL10797918 0.79 L3MBTL3 (0.59) OPRM1OPRD1OPRK1OPRL1
SCHEMBL16226399 0.77 ACHE (0.51) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL14699666 0.77 MGLL (0.48) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL8477673 0.77 ACHE (0.51) ACHEOPRM1OPRD1OPRK1OPRL1
SCHEMBL14280201 0.76 ACHE (0.71) ACHEOPRM1OPRD1OPRK1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009151152-A1 OXYCARBAMOYL COMPOUNDS AND THE USE THEREOF SHIONOGI & CO., LTD. (JP) 2009-12-17 WO disclosed
US-5683998-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, ANTIPAF AGENTS TORAY INDUSTRIES, INC. (JP) 1997-11-04 US disclosed